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AGRICULTURAL BIOTECHNOLOGY AND THE THIRD
WORLD
Tlu impaa on less developed countrizs (ldcs) of advances in
agiculrural biotcchralogy wos recently examincd at an ODI
conference. Thb Briefing Paper draws on somc ofthe work of
tlu anference to exphin the nature and likely pountbl of
agriculwal biouchnalogy; to examine the mtin concems it has
arotued over regulation, gmetic diversity and commercinl
exploitatian; and to consilcr the range of possible applicatians
ond corcequences for developing countries. Thz Paper shows
thc growing imporlance of pivatc sector research and
development in infiistrial countries and indicates the need for
expandcd publicly-fwdcd research in lds and support for the
Inomatiotul Agriculrural Research Centres (IARCs). Thz
Paper explains that the main reason for a dtclining share of ldc
agriculrural exporE in world tradc remabr narthem subsidy
polirizs, not biouchnology, but shows thot there is likely to be
an increasingly adverse irnpac, on ldr trade in speciftr crops as
substitutes become available. On thc othzr hand, there are somc
direa berufits of western biotechnology for ldcs, which include
improved veuinary pro&rc* and somz tissue athure
techniqucs.
What ls dlfferent about agrlcultural
blotechnology?
Biotecbnology applies scientific and engineering principles to
enable materials to be processed by biological agents,
resulting in faster and more accurate breeding programmes
fs1 anim6ls, plants and micro-organisms. It differs from
established methods used in the field (e.g. plant breeding) and
in the facory (e.g. fermentation) in the following ways:
Genetic engineering
Genetic engineering allows scientists acc€ss to the building
blocks of living organisms so that cells or molecules can be
manipulated, and the gene pool available for 'crossing' is
widened beyond the limirc of sexual compatibility. A
secondary set of techniques, based on tissue culture, permits
the rapid regeneration of cells into full-sized plants and
animals, and allows the effects of intervention to be
monitored closely. Apart from their function in 'servicing'
genetic engineering, these techniques are also a useful
addition to conventional breeding programmes.
Linkages across sectors
Biotechnology is characterised by strong linkages across
agricultural and industrial sectors through:
- 
whniques: genetic engineering, cell fuston and cultrre,
embryo rescue and hybridisation.
- 
ptocesses: enzym€ catalysis in starch, detergent and dairy
industries
-rrrolzritls: intermediate products (glucose, fructose,dextrins, lactose) which can be manufactured from a
variety of souroes so that efficient production is less
dependent on individual raw material availability and
price.
Cross linkages favour higher returns per unit of research and
development (R & D) invesfnent among large frrms, and it is
this which has led to some mergeni and takeoven among the
small venture capital companis initially established. Other
factors which have influenced the trend towards larger firms
include the long lag between research outlay and revenue
from the product or pro@ss, and the uncertainty of outcome.
For example, it costs at least $1 million to clone a single gene;
it takes at least 20 man-years to isolate a commercially useful
new enzyme; and only one useful new antibiotic is found for
every 20,ffi strains of organism screened.
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Box l: Gloessry
Amlao ssider The chemical unlts *f wtridr nll pmteins are
mmpo*ed,
Antlsr: lhe ferfiIe aegmenturhich sn$uounb fltes$flfiren(fie malc argan of a plart) and caffies B* poll*n ta*s.
Cell sultfire: A group orcolnmy of *cIIs prcpagafrdfrom *
sir$e cell ln a specifi*al$ formxlat*d nuhient
medium"
CeU fftslon: The firsing tog€ttrer nf two or mme eell* to
become a slngk cell.
Shramosamel A threaGlike body found in cell nuclei,
comsrising gaft€s amaryed in line*r order. tilhile grnm
ara ttre units of heladifi *lmmosomes are the units af
kanemission frcrn cne generation to tlrc next. Duing
rell divisimr clrommomes mqr bteakn reJoin or ctom
ovm giving rise to npw pnefi* combindiorry.
Ol,onel A cdlecfion of genefically identieal ceII$ sr
crgudems doived csexral$from a conmsn ancsstsr,
DNA (Durffihonu*leie acid): Ttris carriec the genetic
kere*itarg msss&ge fird eontrols all *ellular functiors
i$ must fmns 0f lilfe.
Effi$rfo recraue {alro brmed embryo cqrtrre); When
€ros"pollintrtion occur$ befwepn geneticully different
plmrts, t}ru rmr&ing emhyo m*y k ahorted hrcause of
parental m*ual incampatihiltty, $ueh embryos maybe
axlraeted and grvwnoxafi eplropririe medium.
Xnzfmeru $pecific proteine which tct as biologleal
cataUfi*s to n*irudste smnHsl higchemiml reuctinns
in all living orgardems"
Serome: fite entire hereditary meffiage uf wr organimr.
Germphnml Often sgnontrrmous vtth'g*u*tic mrterid' it
is the name gtven to eed or ottmr mater*at ftorn wtdch
plants are propagated,
In rritrol Lit+ra[y'in gls*B'. Expminen&l reproduc$on of
biolo$cal processes in isola#on frsm a lieins
orgnnfsm.
ffionoclond antlho{p An extremely prre antibody
derived ftom a aing$ clone of an antibody-pruducing
ceH. Invadlngpathogerslviral or b*cterial, earry alarge
rnrnrher af different arsigons ench c4able of
Xixruta*q Ste host'* immune syst€m to generate a
comexeoaUing snfibofry.
Faly$mtei nsiving tunr more ttmn one gem.
hotofrrlt*k Apt*ntcelt from whichthp cell wall has been
rmwr*rl by meelunical or eruylffific me&Is.
E*comhfu$,trt trI{A (rI}I{A}: A silrand of D$A
srynt*rfft*ed ,n tlrc laborsfory hy splieing togpther
selested Barts of ttI'IA ${rards from diff€rent oqganic
rpe*ier ur by adding n eelecded part to art exisiing DI,IA
ffim&
Somaelonal v:art&ttom Somstie {vegetatlve non-sexuaf}
plant cellr can be cailsed fi, proBagide m vi&o in an
appropritre nutrient medium. Tht rsfldtant progieny
are called somaclones an* tfeoretisallg fftrould be
genetielly identical witlr the pure*L tu f**t ro ureo eell
culerre of asmf,tic cells fre4rertp g€nsnntes tells
uignifirantly diffrren( gennffcdly, ftom tte, parerrt
Such progeny sre called sonm*krn*I'trartnr*s aild
provide e useful source of gene*ic quiation
Etssus fulmrer In uibo me$hods of prollqudng cells
from animal orplant ti ne-
$ource: Elsfe*iaologn olryorfarf#m and cons&sints, IDRG
Mll0e,Ottowa, 1s46,
d72JI lrrrlt II rrart! /I rrttz I\..."'- -
Private investment
There is greater private, and less public, investment in
biotechnology R & D in industrialised countries than is the
case for conventional agricultural research. Agrochemical
companies with in-house biotechnology R & D capacity now
spend three times the average for R & D in the industry as a
whole, reflecting their confidence in the long-term
commercial potential of genetic engineering and the prosp€ct
of patenting the outcome of research. Agrochemical
companies can exploit the complementarities between their
own products and those generated by biotechnology. For
example, companies can 'package' a plant by genetically
engineering resistance in it to a particular herbicide. They can
thus retain a marketing advantage even after patents on the
herbicide have expired. It is beoming cheaper to tailor a plant
to an agrochemical (rather than vice versa) given the high
costs of conforming to environmental restrictions imposed on
pesticides.
The prospects for biotechnology
Biotechnology is still largely a matter for developed countries.
Many techniques relevant to ldcs are at an early stage of
development, and the application of those currently availableis constrained by limited local research facilities, a
dependence on public funds, and patent difficulties. Except
for a few products, private companies at Present see the
returns to investment in biotechnology for the Third World as
insufficient and too slow. In the north, however, the prospects
are significant in a number of areas, and some have direct
relevance to developing countries.
Markets
Estimates of the value of the world market for all
biotechnology products by 1990 vary widely depending on
how biotechnology is defined, and market forecasts are
hazrrdous, given the long R & D lead times, the
unpredictability of results, and the uncertain regulatory
environment, The production of diagnostic kits, however, is
not subject to strict control and is estimated to have a US
annual market of $1.3 bn by 19$, and that of monmlonal
antlbodles with both veterinary and human applications of
$l.1 bn. The value of the US pharmaceutical market is likely
to be $5.5 bn p.a. by 1990, overshadowing an agricultural
market of only $0.3 bn. This gap is not expected to close for at
least 10 yearS, and reliable crop or animal-specifrc market
estimates are not available. It is likely, however, that
biochemical products will be substituted for petrochemical
products as agricultural prices decline relatively. R-DNA will
facilitate this process, leading to an estimated market of $40
bn p.a. by the year ZX)O for petro-chemical substitutes,
compared with present global sales of cnrde oil of $450 bn p.a.
Plant and animal breeding
Certain genetically engineered plants have now reached the
stage of field trials (e.g. frost resistant strawberries and
potatoes in the USA), but progress has been slow with many
plant types (including cereals), particularly those with traits
which are polygenlcally determined (e.g. yield; tolerance to
drought). Not enough is known about how genes interact and
what gene structures produce particular plant characteristics,
and material still requires testing by growing plants to
maturity and by interaction with conventional breeders.
By contrast, progress has been rapid in supporting
technologies such as tlssue culture, a technique becoming
possible for most plant types and already in commercial use
for fruit and sugar cane, and under trials with tree species such
as oil palm, where conventional reproduction is very slow.
Similarly, ln vttro cultures theoretically allow millions of
individual cells to be screened for suitability within a short
time (to screen 2 million sunflower plants conventionally
would require over 30 hectares of land). In vitro techniques
complement conventional plant breeding and gemplasm
management, reducing the size of some collections by one-
third by eliminating duplication.
A number of'engineered' seeds are likely to be available
commercially by lW2 in industrialised countries, including
herbicide-resistant tobacco, and pest-resistant tobacco,
potato and tomato. Field trials are expected to be under way
by then with some 50 cloned genes of economic importance,
including those for modifying soya plans to produce oil with
the characteristics of sunflower oil.
Substantial progresri serern likely in improving the quality of
a number of products which do not require complex
combinations of genes. Prospects include modifications to
fatty acids in oilseed rape, and genetically enhanced storage
characteristics in legumes, as well as the improvement of shelf
life, fruit texture and flavour in tomatoes.
However, some polygenically-determined trais, such as
nitrogen fixation, are extremely complex. Even if
incorporated in 20-30 years, plants will only be able to create
modest amounts of their own fertiliser in this way. Progress
has also been slow in identifying mechanisms for resistance to
bacterial and fungal diseases because no naturally-occurring
resistance genes have yet been isolated and cloned.
New techniques will lead to gradual increases in the
efficiency of conventional plant breeding in the next decade
and will be passed on to the farmer. These include the various
methods of germplasm management and disease-free
propagation already being used at the International
Agriculture Research Centres (IARCT) which were set up
partly to prepare and distribute genetic material to ldc
breeding programmes (Box 2).
In animal breeding, biotechnology provides a major
commercial potential in enhancing the quality of offtpring and
reducing the time required for reproduction. More than
100,m0 animal embryos with predetermined characteristics
are now being transferred annually to surrogate mothers in
the USA, and 30,0fi) in Europe.
Veterinary products
A variety of new veterinary products will be marketed widely
in the next five years, including diagnostic kits, particularly
those relying on monoclonal antibodies, and growth
hormones for poultry, swine and cattle provided that
government regulations can be met. Developing countries can
currently purchase kis for rinderpest virus diagnosis, and
research is underway to help in distinguishing this from peste
des petits ruminants in the early stages of infection, and to
assist in tracing the souroes of outbreaks.
Vaccines based on r-DNA products are also being
developed for extensive veterinary use, including preventing
neonatal bacterial diarrhoea, foot and mouth disease and
certain herpes viruses.
Fermentation
Industrial fermentation produces both finished products and
food components or additives. Conventional selection and
breeding of the organisms used in fermentation has already
led to high production effidiencies, so that the scope for
further gains through the introduction of 'engineered'
organisms is limited, especia[! in high volume, low unit value
products. More expensive prQducts (such as the le.ss common
emino aclds) offer scope for yield increase, but their complex
polygenic pathways have hitherto prevented rapid progre,ss.
Plant cell culture
Certain plant cell cultures which are used to improve varieties
can be desigred to generate commercial products directly.
However, not enough is known about where and how these
products are synthesised within plant organs, and the prooess
is more costly than bacterial or yeast fermentation. Only
synthesis of expensive compounds such as drugs or fragrances
(with a value of over $lfi)/kg) is likely to be economic. The
only product currently manufactured commercially by cell
culture is shikonin, a dye and pharmaceutical used in Japan,
where consumption has been about 150 kyyear at $4,ffi per kg.
Regulatlng blotechnology
Regulation affects two aspects of research in particular:
patents and health and safety.
Patents
The strong commercial stake in biotechnology R & D requires
patent protection of successful products and processes. But
this may reduce competition and 
- 
an important possible
consequence for ldcs 
- 
may prevent new knowledge from
entering the public domain. Fears about competition may be
overstated since there are many firms involved in
biotechnology R & D, there is continued public funding for it,
and patents are diffrcult to enforce.
There are several impediments to full regulation by patent
in many countries. The extensive descriptions required often
give zufficient detail to allow competitors to 'design around'
the patent. Samples deposited in patents offices may be
forfeited if the application is unsuccessful, allowing
competiton access to them. An added difEculty is that
international patents remain largely unenforceable in
countries not signatory to certain conventions.
Health and safety
The spectre of the uncontrollable spread of dangerous
mutations is feared by organisations and lobby groups seeking
to widen the debate on possible future environmental
degradation and ecological imbalances arising from the use of
biotechnological processes. A Dag Hammarskjold Seminar
addressed this question at BogEve, France, in 1987 and
concluded in the BogEve Declaration that an international
biotechnology policy agreement was required which met *the
needs of the majority of the world's people...while working in
harmony with the environment."
However, many forthcoming trials appear relatively 'safe'.
They involve genes which are naturally occurring (albeit in a
different host), are conducted with hosts unlikely to have
vigorous crossing capacity either within or across species, or
they involve the removal of genes rather than the addition of
foreign ones. Permission has now been given in the USA for
field trials of 'low risk' genetically engineered organisms, and
decentralised regulation of trials is likely. The situation in
Europe is more confused: West Germany and the
Scandinavian countries have severely restricted field trials,
although several have been conducted in Britain, and Italy
appears to have no restrictive legislation. Efforts are now
being made to desigr a coordinated European approach to
field testing.
Gene banks
The incorporation of new genetic traits into plants or animals
may reduce the need to maintain genetic diversity in the freld.
Indeed, genetic erosion has accelerated with the Green
Revolution: in south-east Asia, for example, a single rice
variety (IR 36) now coven ()7o of the rice area. This may
increase wlnerability to pests and diseases, recalling the stem
rust which destroyed almost 50% of the USA and Canadian
wheat crop in 195G54. However, the prospects of introducing
'foreign' genes remains so poor for many crops and traits that
naturally-occurring germplasm still provides breeders with a
more useful set of building blocks.
Scientists accept that divenity must be maintained, but it
does not follow that the entire range of species has to be grown
in the field. In areas where agroecological conditions vary
widely, farmers maintain diversity through their need for
several different strains to cope with varied conditions. In
more uniform areas, the risks of rellng on fewer varieties are
now much reduced. Breeders incorporate resistance to pests
and diseases that does not rely on a single gene and is
therefore not prone to sudden breakdown. The characteristics
of the wide range of genetic material now held at the IARCs
have been classified and new sources of resistance can be bred
quickly into commercial crops if some breakdown is
threatened. Additionally, techniques such as protoplast
fusion are generating new resistant germplasm, for example
through crosses between sexually incompatible wild and
cultivated varieties.
Developing countrles and blotechnology
Research and development
Conventional plant breeding in developing countries presents
a varied picture, with some Asian countries well-advanced,
and, in Africa particularly, some countries making hardly any
progress. This range is important as conventional and
biotechnology-based methods of plant breeding are highly
complementary. Tissue culture makes it easier both to
compile germplasm collections and to supply disease-free
material of known characteristics. Gene insertion techniques
broaden the range of genetic variation from which breeders
can make crosses, But the search for genetic diversity is the
less difficult component of plant breeding. The selection of
Eox & Intematiqnal Agriculture
Research Contras y$ith pnrtlcular crop
or animal prduction mandalss
fiIAt * krternational Centre far ?ropical Agic.trlfirre:
hearu, cassava, rice, tropical partures.
CIBIMIT * International Maiae and Whert lmprovement
Cerrbel wheat, maize, bitiealf.
CIf * Intarrrdional Potato Centrer pofatoes and sweet
potdoec.
ICABIA 
- 
tuternationatr Cffibe for Agyicnltural
Eeseach in the DryAreas:barley, lentilr, fabe bearus,
ICBISAf 
- 
Internfrionsl Oentre for Seeearch tn the$emir&rid Tlopics: mill€t, sorghurn, gformdnut
ctriclEpeq pigeonpea
IIfA * International IfiSiffit€ of Tropical Agiculkre:
,oots aildh$sfl, sosFsfi, soya"
ILCA 
-Interra$onal Ltveotock Cenbe for Afrlca cattle,smstl rurdnsnts, eflfild$.
ILBAD * Interna*tanal Labor*tory for Eesearch an
Animal Diseases: fipanosomiasis, Erat Coaat fever.
TItIil * International fiiee Hesearch Institufs; riee.
ffiABIIA 
- 
West Afrlean Hice Ilevetopment Assoeialion:
riee.
Ihe IARCs tre intended to cflpture the economies of
scale in research which are unlikely to be auailable to the
smaller ldcs. ?hey lwld m{or germp}asm collections fsr
particular crop& andarerccrponsible for *re distribution of
breeders' material to ldcs. Substentiat emphasis is
therefore placed on biotechnolo€i€s relevart tr the
pmduction or screenlng of clonal materiat dsrftr€d
through rn ri&p micropropagation. Thr$s includel
tilrWid clanal prapagation: proved successfitl {rdfh
hanaflr, firber$ and otl palq arrd shows promise In fruit,
medkirral plsnt6, and fsrest trees. Its pa*icular
advantages includel rapid and disease-free nxrltiplica$orq
the abillty to propagats spectes which are difFeult to
reproduce vegetatively, and Brcduetiorr of plant maieriat
on a year-round hasi+
(i$ in rafo conserraffom used extensfuety with c*asarar
potat$, sweet potato and baffina- fitese techniqtres ofrer
an alternafive to the maintengnee of freld colleetions, but
prohlems rrise from the genetk instability of crop.specific
culfires of somaslonal varifinF.
{iti} drsea.seSee plwt Fmduc*ion: vfrus-ftee fiesue can
be obtained from over ffi xp*cies of plants important to
ldrs through fhe use of chemo- and thermotherapy and
sntibio$cs. Germplasm derived frsm tlrese is dlsffibuted
to ldcs to form drc basis of their breeding programmes.
{fu}moleculw *agroshes; faster and more a$eumte
virus detecdion techniEres uxed on rice, and smnll grains
Tlre IARCs are also usingthe more adnaxrced techniguesto
facilltafe producf$on of germplasm in ulko:
(i) embryo rescue.' facflitstes incorpom,6on of genetic
material ftom beyond the prtmry gene pool into cmp
improvement programmes. Follow{ng sexually-indueed
tryhridizotio4 fhe embryo is ntrsed by tismre culUre
techniques thmugfr the early cell divisions unHl tt
resan€rstes as a plant Using ovule and embryo resue,
trogeUmr *rith hormone beaffnent, seien$sts have
incorporated diseaae rtul$hnee inta plants (e,g rice,
groundnut ard potrto) by susxing wild and rultivuted
rrurieties which are sexufllly ineonqaffble.
tii)sornfiGran , oartatlrrn: ssmsclon€s are etreened
fortnlerance to saltaod other eavirqnmentalskessps. Thi$
may prove a useflrl addiffon to the variation ayailahlc to
breedss hom existing gene pools, providingthatin yl&r-
in*lcdvariation proves *ahle in field trials.(iii)*ntker culturc: dertuing cultures ftom pollen cells
can shorten breeding cyclea and ircrease seleetion
efficiency. Conventlonal breeding eycle periods can be eut
by more than hdf, tolerance to col{ drought eftd oalinity
canbe bred andplant regrneration efficienciesftom tis.$e
cilItures car be improve&
{iv}e-ryerfnental fexhniryesr more sophisticated and
eostly techniques include the development of markew
desipted to identi$ the large bloeks of DNA or
chromosome segment6 tltat contribute to qratitative
ehara.cters such as yield. Ttrese rnay asrist the breeder in
systemaiically testing and assemhling the building blocke
of the genomes sought, augmenting the empirical
proceduras currently used
useful characters from the available diversity is more time
consuming, and, since knowledge of the types of trait
produced by particular genes is far. from complete, plants
which are modified either by genetic engineering or
conventional crossing still have to be grown out to maturity in
successive cycles of breeding-in desirable characteristics and
breeding-out undesirable ones.
Many of the smaller and poorer countries lack the facilities
even for conventional plant breeding, and certainly could not
undertake tissue culture or genetic engineering. India,
however, has a National Bureau for Plant Genetic Resources
where substantial progress has been made with germplasm
conservation through tissue culture techniques, and where
research is being conducted on in vitro conservation.
Agricultural conditions tend to vary considerably in most
ldcs, so that a wide range ofproduce is grown, and the internal
market for each tends to be limited. Private sector
biotechnology R & D has therefore been limited to certain
crops, prooesses and countries, mainly with a view to potential
export markets, and has generally been undertaken by
multinationals. Reproduction of oil-palm by tissue culture is a
well-known example for which large-scale field trials are
under way, although its economic viability has not yet been
established.
By 1983 in Brazil there were already 6{X) research scientists
in biotechnology-related activities, with strong private sector
involvement in tobacco research and the production of
hormones, inoculants and vaccines through fermentation.
The expansion of private sector research, however, faces
obatacles such as the impossibility of patenting seeds, and
import restrictions urged by a protectionist domestic
equipment industry.
Most biotechnology research in ldcs will continue to be
publicly funded, and the majority of these countries will
require external support 
- 
from the IARC-s in particular (see
Box 2) 
- 
for their agricultural research efforts if they are to
capitalise on biotechnology. There have also been efforts to
establish a new multilateral publicly-funded institution, the
LJMDO International Centre for Genetic Engineering and
Biotechnology (ICGEB); but despite its potential importance
as a research centre, its future remains uncertain.
The impact of biotechnology
Synthab substitwcs.'Attempts have been made for decades in
the North to synthesise substitutes for products generally
imported from ldcs, but biotechnology-based substitutes have
so far been modest in scope. High fructose corn synrp is the
exception, the success of which in capturing some 407" of the
US sweetener market is attributable to a combination of
improved ewnyme technology, other improvements in the wet
milling of maize and long-standing subsidies to and protection
of the US maize industry (although US sugar beet is also
subsidised). The high costs of plant cell culture, and the
limited scope for cost reductions mean that synthesis is
unlikely to produce anything other than high value ($100ftg),
low volume substitutes in the next decade. Claims have been
made, however, that work in progress will reduce the costs of
culturing vanilla from its present $20(X)/kg to $50/kg, which
would make it price-competitiye with the conventionally-
grovm product.
Fermenutian: An important development in the fermentation
industry is the capacity to use an increasing range of
agricultural products (or by-products) as raw material for
extraction of specific chemicals, switching from one to another
as market conditions change. Some markets (e.g. for
vegetable oils) may consequently become more volatile,
increasing the disadvantage faced by producing countries
which do not have easy and rapid routes to world markets or
which are highly dependent on a narrow range of products for
their export earnings.
However, the scope for improvements to fermentation
processes through genetic engineering is limited to a few
higher value products such as vitamins and antibiotics. This is
partly because processing accounts for only a small proportion
of total costs and partly because conversion to the final
product is already very efEcient in bulk processes (e.g. for
citric acid, monosodium glutamate, penicillin and riboflavin).
Trade: Protectionist policies for major food commodities
cause distortions to trade between the West and ldcs at a net
current cost to ldcs of about $7fi) million per year.' Accordingto recent official US frgures, industrialised countries'
agricultural exports have risen to 630/o of world agricultural
trade in 1988, from 42Y" in the early 1960s. The main reason
for such an increase is the level of subsidies and concomitant
protection; such policies are likely to outweigh the effects on
prices and trade of better productivity arising from
biotechnology during the next 10-15 years, both in aggregate
and in major traded crops. Such effects as may be felt in ldcs
will depend on whether they are importers or exporters of the
commodity in question.The main, foreseeable, impact of agricultural
biotechnology on developing countries'trade will be chiefly in
low-volume, high value products. This could threaten
countries relying heavily on traditional methods for
production of such crops. But the biotechnological
innovations currently being developed represent only a small
fraction of the potential, and the rate of innovation is likely to
accelerate in the next century, so that no country will remain
immune to trade or production effects.
* Assessments of the net costs to developing oountries arising from
the West's protectionist food and agricultural policies vary
considerably. For details, see The CAP and is Impaa on the Third
World, ODI Briefng Paper, June 1986.
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